{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:12:45Z","timestamp":1790986365051,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3032,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1111\/j.1365-2133.2007.07942.x","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T12:08:18Z","timestamp":1179144498000},"page":"133-141","source":"Crossref","is-referenced-by-count":104,"title":["Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3\u2003days per week in one or two courses of treatment of actinic keratoses on the head"],"prefix":"10.1093","volume":"157","author":[{"given":"A.","family":"Alomar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"McRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,5,14]]},"reference":[{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(97)70265-2","article-title":"Actinic keratosis","volume":"36","author":"Callen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1085-5629(99)80003-0","article-title":"Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses","volume":"18","author":"Yantsos","year":"1999","journal-title":"Semin Cutan Med Surg"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2007.07942.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1111\/j.1440-0960.1997.tb01005.x","article-title":"Solar keratoses and their relationship to non-melanoma skin cancers","volume":"38","author":"Kocsard","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000069957","article-title":"Nudging epidermal field cancerogenesis by imiquimod","volume":"206","author":"Uhoda","year":"2003","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00000372-200110000-00020","article-title":"Incidental histopathologic pattern: possible evidence of field cancerisation surrounding skin tumors","volume":"23","author":"Carlson","year":"2001","journal-title":"Am J Dermpathol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jlb.58.3.365","article-title":"Cytokine induction by the immunomodulators imiquimod and S-27609","volume":"58","author":"Testerman","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1523-1747.1998.00174.x","article-title":"Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463","volume":"110","author":"Imbertson","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2004.02.022","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology","volume":"51","author":"Szeimies","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.141.4.467","article-title":"Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials","volume":"141","author":"Korman","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-4632.2004.02056.x","article-title":"A prospective study of the use of cryosurgery for the treatment of actinic keratoses","volume":"43","author":"Thai","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0149-2918(02)80012-1","article-title":"Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis","volume":"24","author":"Loven","year":"2002","journal-title":"Clin Ther"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10227-005-0148-6","article-title":"Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: critical review and meta-analysis of efficacy studies","volume":"9","author":"Gupta","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(97)06088-1","article-title":"Randomised, double-blind, placebo-controlled trial of interferon [alpha]-2b with and without ribavirin for chronic hepatitis C","volume":"351","author":"Reichard","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1084\/jem.162.2.516","article-title":"Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation","volume":"162","author":"Duncan","year":"1985","journal-title":"J Exp Med"},{"issue":"6 Suppl.","key":"10.1111\/j.1365-2133.2007.07942.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1111\/1523-1747.ep12874789","article-title":"Interferons and collagen production","volume":"95","author":"Granstein","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/jlb.69.4.513","article-title":"Chemokines in cutaneous wound healing","volume":"69","author":"Gillitzer","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1365-2133.2007.07942.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-3083.1998.tb00710.x","article-title":"Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical study","volume":"10","author":"Tucci","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2007.07942.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2007.07942.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T08:11:22Z","timestamp":1707898282000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/157\/1\/133\/6641086"}},"subtitle":["Imiquimod 5% cream - safety and efficacy study"],"short-title":[],"issued":{"date-parts":[[2007,5,14]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07942.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5,14]]}}}